BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 33746735)

  • 1. Widespread Decreases in Cerebral Copper Are Common to Parkinson's Disease Dementia and Alzheimer's Disease Dementia.
    Scholefield M; Church SJ; Xu J; Patassini S; Roncaroli F; Hooper NM; Unwin RD; Cooper GJS
    Front Aging Neurosci; 2021; 13():641222. PubMed ID: 33746735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe and Regionally Widespread Increases in Tissue Urea in the Human Brain Represent a Novel Finding of Pathogenic Potential in Parkinson's Disease Dementia.
    Scholefield M; Church SJ; Xu J; Patassini S; Roncaroli F; Hooper NM; Unwin RD; Cooper GJS
    Front Mol Neurosci; 2021; 14():711396. PubMed ID: 34751215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson's Disease Dementia.
    Scholefield M; Church SJ; Xu J; Patassini S; Hooper NM; Unwin RD; Cooper GJS
    Metabolites; 2021 Aug; 11(9):. PubMed ID: 34564384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localized Pantothenic Acid (Vitamin B5) Reductions Present Throughout the Dementia with Lewy Bodies Brain.
    Scholefield M; Church SJ; Xu J; Patassini S; Cooper GJS
    J Parkinsons Dis; 2024 May; ():. PubMed ID: 38820022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma metals as potential biomarkers in dementia: a case-control study in patients with sporadic Alzheimer's disease.
    Xu J; Church SJ; Patassini S; Begley P; Kellett KAB; Vardy ERLC; Unwin RD; Hooper NM; Cooper GJS
    Biometals; 2018 Apr; 31(2):267-276. PubMed ID: 29516299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for widespread, severe brain copper deficiency in Alzheimer's dementia.
    Xu J; Church SJ; Patassini S; Begley P; Waldvogel HJ; Curtis MA; Faull RLM; Unwin RD; Cooper GJS
    Metallomics; 2017 Aug; 9(8):1106-1119. PubMed ID: 28654115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Widespread selenium deficiency in the brain of cases with Huntington's disease presents a new potential therapeutic target.
    Scholefield M; Patassini S; Xu J; Cooper GJS
    EBioMedicine; 2023 Nov; 97():104824. PubMed ID: 37806287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-regional alterations in glucose and purine metabolic pathways in the Parkinson's disease dementia brain.
    Scholefield M; Church SJ; Taylor G; Knight D; Unwin RD; Cooper GJS
    NPJ Parkinsons Dis; 2023 Apr; 9(1):66. PubMed ID: 37081022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of pathological markers in Parkinson's disease dementia post-mortem brains compared to dementia with Lewy bodies.
    Tu H; Zhang ZW; Qiu L; Lin Y; Jiang M; Chia SY; Wei Y; Ng ASL; Reynolds R; Tan EK; Zeng L
    BMC Neurosci; 2022 Jan; 23(1):3. PubMed ID: 34983390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
    Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroinflammation and protein pathology in Parkinson's disease dementia.
    Kouli A; Camacho M; Allinson K; Williams-Gray CH
    Acta Neuropathol Commun; 2020 Dec; 8(1):211. PubMed ID: 33272323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparative White Matter Study with Parkinson's disease, Parkinson's Disease with Dementia and Alzheimer's Disease.
    Perea RD; Rada RC; Wilson J; Vidoni1 ED; Morris JK; Lyons KE; Pahwa R; Burns JM; Honea RA
    J Alzheimers Dis Parkinsonism; 2013 Aug; 3():123. PubMed ID: 24724042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
    Rolinski M; Fox C; Maidment I; McShane R
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging.
    Zecca L; Stroppolo A; Gatti A; Tampellini D; Toscani M; Gallorini M; Giaveri G; Arosio P; Santambrogio P; Fariello RG; Karatekin E; Kleinman MH; Turro N; Hornykiewicz O; Zucca FA
    Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9843-8. PubMed ID: 15210960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcranial Sonographic Alterations of Substantia Nigra and Third Ventricle in Parkinson's Disease with or without Dementia.
    Dong ZF; Wang CS; Zhang YC; Zhang Y; Sheng YJ; Hu H; Luo WF; Liu CF
    Chin Med J (Engl); 2017 Oct; 130(19):2291-2295. PubMed ID: 28937033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, distribution, and severity of cerebral amyloid angiopathy differ between Lewy body diseases and Alzheimer's disease.
    Walker L; Simpson H; Thomas AJ; Attems J
    Acta Neuropathol Commun; 2024 Feb; 12(1):28. PubMed ID: 38360761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that levels of nine essential metals in post-mortem human-Alzheimer's-brain and ex vivo rat-brain tissues are unaffected by differences in post-mortem delay, age, disease staging, and brain bank location.
    Scholefield M; Church SJ; Xu J; Kassab S; Gardiner NJ; Roncaroli F; Hooper NM; Unwin RD; Cooper GJS
    Metallomics; 2020 Jun; 12(6):952-962. PubMed ID: 32373908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral bioimaging of Cu, Fe, Zn, and Mn in the MPTP mouse model of Parkinson's disease using laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS).
    Matusch A; Depboylu C; Palm C; Wu B; Höglinger GU; Schäfer MK; Becker JS
    J Am Soc Mass Spectrom; 2010 Jan; 21(1):161-71. PubMed ID: 19892565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's Disease Dementia Patients: Expression of Glia Maturation Factor in the Brain.
    Thangavel R; Kaur H; Dubova I; Selvakumar GP; Ahmed ME; Raikwar SP; Govindarajan R; Kempuraj D
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metals linked with the most prevalent primary neurodegenerative dementias in the elderly: A narrative review.
    Mateo D; Marquès M; Torrente M
    Environ Res; 2023 Nov; 236(Pt 1):116722. PubMed ID: 37487923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.